THE FIRST ALL-RUSSIAN PHARMACOEPIDEMIOLOGICAL STUDY «EPIDEMIOLOGY OF DRUG USE IN PREGNANT WOMEN»: BASIC RESULTS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To study drug-prescribing tactics for pregnant women in different regions of Russia. Subjects and methods. A one-stage multicenter pharmacoepidemiological study was conducted. Questionnaire surveys were made among 1286 physicians of different specialties and 2324 pregnant women and puerperas. Results. Most physicians have been shown to be inadequately aware of the processes of organogenesis. It has been ascertained that the physicians prescribe a wide range of drugs to pregnant women and recommend drugs with unstudied safety to a fetus and those that are contraindicated in pregnancy. The pregnant women show a low adherence to the prescribed therapy and a high self-treatment rate. Subjects and methods. A one-stage multicenter pharmacoepidemiological study was conducted. Questionnaire surveys were made among 1286 physicians of different specialties and 2324 pregnant women and puerperas. Conclusion. It is necessary to update branch standards and to introduce pregnancy management protocols according to the data of evidence-based medicine, to adjust drug use instructions in accordance with updated clinical recommendations, to elaborate educational programs for the therapy of somatic diseases in pregnancy for physicians of different specialties, to set up an effectively operating pharmacovigilance system to monitor adverse reactions occurring with drug use in pregnancy, and to initiate the creation and maintenance of registers for using drugs in pregnant women.

Full Text

Restricted Access

About the authors

O. N TKACHEVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: tkacheva@rambler.ru

A. Yu BEVZ

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

E. A USHKALOVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

N. A CHUKHAREVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

References

  1. Астахова А.В., Лепахин В.К. Лекарства. Неблагоприятные побочные реакции и контроль безопасности. — М.: Эксмо, 2008.
  2. Шефер К., Шпильтанн Х., Феттер К. Лекарственная терапия в период беременности и лактации. — М.: Логосфера, 2010.
  3. Anger G.J., Piquette-Miller M. Pharmacokinetic studies in pregnant women // Clin. Pharmacol. Ther. — 2008. — Vol. 83, № 1. — P. 184—187.
  4. Czeizel A.E. Epidemiological studies of congenital abnormalities in Hungary // Issues and reviews in teratology / Ed. H. Kalter-Dordrecht: Kluwer Academic Publishers, 2000. — Р. 85—124.
  5. Donati S., Baglio G., Spinelli A., Grandolfo M.E. Drug use in pregnancy among Italian women // Eur. J. Clin. Pharmacol. — 2000. — Vol. 56, № 4. — Р. 323—328.
  6. European Medicines Agency. Announcement of European Medicines Agency priorities for adverse drug reaction research. — London, 4 August 2009 Doc. Ref. EMEA/497624/2009. http://www.ema.europa.eu/pdfs/human/phv/49762409en.pdf.
  7. FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy. For Immediate Release: Dec. 30, 2009. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm195934.htm.
  8. Lo W.Y., Friedman J.M. Teratogenicity of recently introduced medications in human pregnancy // Obstet. and Gynecol. — 2002. — Vol. 100. — Р. 465—473.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies